Jordan L. Schultz

In this installment, Jordan L. Schultz, an Assistant Professor of Neurology and Psychiatry at the University of Iowa, discusses his research on β-blockers and their role in Huntington's disease. Schultz highlights how these medications might delay the disease's onset and progression. He explores findings showing that patients on β-blockers enjoy better clinical outcomes and lower motor diagnosis risks. The conversation also delves into the use of different types of β-blockers and their potential impact on psychiatric symptoms, calling for further research.